Effect of Intralipid Infusion in Patients With Recurrent Implantation Failure

Summary

The aim of present study is to evaluate the effect of intralipid 20% infusion, once between days 4 and 9 of the ovarian stimulation, and again within 7 days of a positive pregnancy test on clinical pregnancy rates in women with unexplained recurrent implantation failure.

Timeline

Start

2016-07

Primary completion

2017-07

Completion

2017-08

Drugs

Indications